Tilray Brands, Inc. (TLRY)
| Market Cap | 1.40B |
| Revenue (ttm) | 830.77M |
| Net Income (ttm) | -2.15B |
| Shares Out | 1.13B |
| EPS (ttm) | -2.30 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 38,094,822 |
| Open | 1.200 |
| Previous Close | 1.210 |
| Day's Range | 1.170 - 1.250 |
| 52-Week Range | 0.351 - 2.320 |
| Beta | 2.10 |
| Analysts | Buy |
| Price Target | 1.50 (+20.97%) |
| Earnings Date | Oct 9, 2025 |
About TLRY
Tilray Brands, Inc., a lifestyle consumer products company, engages in the research, cultivation, processing, and distribution of medical cannabis products in Canada, the United States, Europe, the Middle East, Africa, and internationally. The company operates through four segments: Beverage, Cannabis, Distribution, and Wellness. It also offers medical and adult-use cannabis products; resells and distributes pharmaceutical and wellness products; and produces, markets, and sells beverage products, and hemp-based food products. In addition, the c... [Read more]
Financial Performance
In 2025, Tilray Brands's revenue was $821.31 million, an increase of 4.10% compared to the previous year's $788.94 million. Losses were -$2.19 billion, 792.6% more than in 2024.
Financial StatementsAnalyst Summary
According to 3 analysts, the average rating for TLRY stock is "Buy." The 12-month stock price target is $1.5, which is an increase of 20.97% from the latest price.
News
Top Canadian Cannabis Stocks to Watch in November 2025
The Canadian cannabis market continues to evolve as global demand expands and U.S. legalization remains a hot topic. Investors are watching closely as several major producers position themselves for r...
Tilray Medical Sets the Standard for Compassionate Pricing, Broadening Access to Medical Cannabis for Patients, Seniors, First Responders, and Veterans Through Expanded Pricing Programs Across Canada
LEAMINGTON, Ontario, Nov. 04, 2025 (GLOBE NEWSWIRE) -- Tilray Medical a division of Tilray Brands, Inc. (NASDAQ: TLRY and TSX: TLRY) and a global leader in medical cannabis, empowering the therapeutic...
'Trump effect' raises hopes for cannabis rally as investors bet on federal reforms, softer marijuana stance
Cannabis stocks could rally on hopes for new hemp regulations and Trump's possible softer stance on marijuana, fueling investor optimism across the industry.
Tilray Brands Sets Sights on Asia: Bringing Award-Winning Craft Beers to Japan's Premier American Craft Beer Experience Festival
NEW YORK, Oct. 30, 2025 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. (NASDAQ: TLRY and TSX: TLRY), a global lifestyle and consumer packaged goods company at the forefront of the beverage, cannabis and well...
Canadian Cannabis Leaders Poised for Growth as U.S. Legalization Momentum Builds
The Canadian cannabis sector continues to attract attention as investors look for opportunities amid renewed optimism surrounding U.S. legalization. The U.S. cannabis industry is projected to exceed $...
Redhook Brewing Launches Redhook 81, Celebrating Pacific Northwest Roots and the Spirit of Hard Work
SEATTLE, Oct. 23, 2025 (GLOBE NEWSWIRE) -- Redhook Brewing, creator of the hardest working beer in the fridge and a craft brand by Tilray Brands, Inc. (NASDAQ: TLRY and TSX: TLRY), a global lifestyle ...
Tilray Brands Marks Seven Years of Cannabis Legalization in Canada with the #1 Market-Leading Position by Revenue and Pioneering Brands with Growing Market Share in the World's Largest Federally Legal Cannabis Market
TORONTO, Oct. 17, 2025 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. ("Tilray" or the "Company") (Nasdaq: TLRY; TSX: TLRY), a global lifestyle and consumer packaged goods company at the forefront of the glo...
Tilray Stock Rises As Study Links Medical Cannabis To Lower Opioid Use
Tilray Brands Inc (NASDAQ:TLRY) shares are trading higher on Wednesday after a Marijuana Moment report cited findings from a new study showing medical cannabis legalization leads to significant reduct...
Tilray Medical Announces Expansion Plans in Panama, Strengthening Global Cannabis Leadership and Accelerating International Growth
NEW YORK, Oct. 13, 2025 (GLOBE NEWSWIRE) -- Tilray Medical (“Tilray”), a division of Tilray Brands, Inc. (NASDAQ: TLRY and TSX: TLRY) and a global leader in medicinal cannabis, empowering the therapeu...
Tilray stock price forecast as a shooting star candle forms
Tilray stock price surged to the highest point since April last year and then pulled back after its mixed financial results. TLRY's US shares ended the week at $1.72, down by 26% from its highest poin...
Top 3 Canadian Cannabis Stocks to Watch in October 2025
The Canadian cannabis sector continues to attract investors as North American legalization momentum gains strength. Recently, U.S. regulators advanced discussions on cannabis rescheduling, signaling a...
Tilray Reports Strong Q1-2026 Earnings As The Cannabis Sector Rallies
Tilray reported strong Q1-2026 results with net income and revenue growth, sparking a sector-wide rally in cannabis stocks. Tilray's performance was driven by international and Canadian cannabis sales...
Tilray Brands, Inc. (TLRY) Q1 2026 Earnings Call Transcript
Tilray Brands, Inc. (NASDAQ:TLRY) Q1 2026 Earnings Call October 9, 2025 8:30 AM EDT Company Participants Berrin Noorata - Chief Corporate Affairs Officer Irwin Simon - President, CEO & Chairman Carl ...
Tilray stock: why options data is skewed to downside despite solid Q1 earnings
Tilray Brands Inc (NASDAQ: TLRY) soared on market open today after coming in ahead of Street estimates for its fiscal Q1, with net income printing at $1.5 million and revenue climbing to a record $210...
Tilray: Another Blah Quarter
Tilray Brands surged after FQ1 results, but the business shows minimal growth and is no longer focused on key cannabis sales. TLRY's revenue growth was driven mainly by acquisitions and currency gains...
Tilray Delivers Q1 Earnings Surprise, Strengthens Balance Sheet With Lower Debt
Tilray Brands Inc. (NASDAQ:TLRY) stock is surging on Thursday after the cannabis company reported better-than-expected first-quarter 2026 earnings.
Tilray Brands Reports Strong First Quarter Fiscal 2026 Results, Highlighting Continued Growth with Record Q1 Net Revenue of $210 Million and Net Income
Operational Efficiencies and Focus on Profitability Drove Net Income of $1.5 Million, Adjusted EBITDA Increased 9% to $10 Million and Net Cash Used in Operations Improved by $34 Million Year-Over-Yea...
Tilray Brands Gears Up For Q1 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts
Tilray Brands, Inc. (NASDAQ:TLRY) will release earnings results for the first quarter, before the opening bell on Thursday, Oct. 9.
Tilray stock price forecast ahead of earnings: buy, sell, or hold?
Tilray stock price has been in a strong bull run in the past few months, making it one of the best-performing companies in Wall Street. TLRY jumped from a low of $0.355 in June and peaked at $1.88 thi...
How to play cannabis stocks now: An investor's playbook
Cannabis stocks are in focus after President Trump said CBD could "revolutionize senior healthcare" in a Truth Social post. The comment sent bullish signals through the cannabis space, coming months a...
Tilray stock price forecast as it faces major headwinds
Tilray stock price has surged in the past few weeks, with most of the gains happening on Monday when it surged by over 60%, which brought its market capitalization to over $2 billion. It has now soare...
Best Canadian Cannabis Stocks to Watch for Growth and Opportunity
The U.S. cannabis industry has expanded rapidly, now generating over $33 billion in annual sales. Analysts project the market could exceed $56 billion by 2030. These figures highlight the growing oppo...
Wall Street Breakfast Podcast: Weed Stocks Light Up
Cannabis stocks surged after Trump endorsed CBD for senior healthcare, citing its potential to revolutionize treatment and reduce healthcare costs. Shares of TLRY, CGC, CRON, and ACB soared double dig...
Tilray, a Global Leader in Medical Cannabis, Announces Expansion of Premium Craft Cannabis Production at its Advanced EU-GMP Facility in Germany; Tilray Medical Enhances Tilray Craft Cannabis Portfolio with New Patient-Centered Offerings
NEUMÜNSTER, Germany, Sept. 30, 2025 (GLOBE NEWSWIRE) -- Tilray Medical a division of Tilray Brands, Inc. (NASDAQ: TLRY and TSX: TLRY) and a global leader in medicinal cannabis, empowering the therapeu...
Cannabis stocks soar after Trump shares video promoting drug's use for seniors
Video posted on Truth Social touts CBD as a ‘gamechanger' and promotes Medicaid coverage of CBD products